Vicarious Surgical (RBOT) Price & Analysis

Compare

263 Followers

RBOT Stock Chart & Stats

$1.82

-$0.68(-4.53%)

At close: Jan 08 4:00 PM EST

$1.82

-$0.68(-4.53%)

Day’s Range― - ―

52-Week Range$0.27 - $13.75

Previous CloseN/A

Volume30.88K

Average Volume (3M)90.39K

Market Cap

$6.84M

Enterprise Value$11.43M

Total Cash (Recent Filing)$9.79M

Total Debt (Recent Filing)$7.79M

Price to Earnings (P/E)―

Beta2.13

Next Earnings

May 11, 2026

EPS Estimate

-1.2

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.65

Shares Outstanding6,468,185

10 Day Avg. Volume138,739

30 Day Avg. Volume90,387

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)1.31

Price to Sales (P/S)0.00

P/FCF Ratio-0.29

Enterprise Value/Market Cap1.67

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-17.78

Enterprise Value/Ebitda-0.23

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-4.07

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Commercialization MilestoneTarget to deliver a design-frozen, production-equivalent system with required commercialization features by year-end 2026 could materially de-risk the path to market.

Risk-reducing Execution ShiftRefocusing on achieving design freeze rather than pursuing an earlier clinical start reduces technical and regulatory execution risk and clarifies operational priorities.

Strategic OutsourcingPlanned partnership with a consultant to outsource certain components aims to reduce cash burn and sharpen focus on proprietary technology development.

Bears Say

Analyst SentimentAnalyst's neutral recommendation reflects delays in product development and a challenging macroeconomic backdrop, suggesting investors may prefer to wait for clearer progress.

Capital Runway RiskAnalysts warn the company may exhaust cash by early fiscal 2026 without significant cuts to cash burn or new financing, creating funding pressure for continued development.

Extended Development TimelineDesign freeze timeline extended to the end of fiscal 2026 from a mid-fiscal 2026 target, increasing uncertainty on product readiness and launch timing.

Vicarious Surgical News

Vicarious Surgical announces plan to pursue Nasdaq listing

Vicarious Surgical (RBOT) announced a series of strategic actions to support a potential relisting of its common stock...

8d ago

RBOT

Vicarious Surgical receives delisting notice from NYSE

Vicarious Surgical (RBOT) announced that it received a notice from the NYSE that the NYSE has commenced the...

20d ago

RBOT

NYSE to begin delisting procedures against Vicarious Surgical

The New York Stock Exchange announced that it will commence delisting procedures against Vicarious Surgical (RBOT). Published first...

21d ago

RBOT

Vicarious Surgical Delisted to OTC as Losses Narrow

Vicarious Surgical ( ($RBOT) ) has provided an announcement. On March 3, 2026, the New York Stock Exchange...

15d ago

RBOT

Vicarious Surgical Implements Executive Salary Reductions, Maintains Incentives

The latest update is out from Vicarious Surgical ( ($RBOT) ). On March 4, 2026, Vicarious Surgical Inc....

18d ago

RBOT

Vicarious Surgical Announces NYSE Delisting and OTC Transition

Vicarious Surgical ( ($RBOT) ) has shared an announcement. On March 3, 2026, Vicarious Surgical received notice that...

20d ago

RBOT

Vicarious Surgical Enhances CEO and CFO Severance Protections

Vicarious Surgical ( ($RBOT) ) has provided an announcement. On February 2, 2026, Vicarious Surgical Inc. amended the...

2M ago

RBOT

Vicarious Surgical Stockholders Approve Warrant Exercise Proposal

Vicarious Surgical ( ($RBOT) ) just unveiled an update. On January 9, 2026, Vicarious Surgical Inc. held a...

2M ago

RBOT

Vicarious Surgical announces software partnership to streamline operations

Vicarious Surgical (RBOT) announced that it has entered into a strategic partnership agreement with a global digital engineering...

3M ago

RBOT

Vicarious Surgical Announces 2026 Cash Burn Guidance

Vicarious Surgical ( ($RBOT) ) just unveiled an update. On December 12, 2025, Vicarious Surgical Inc. entered into...

3M ago

RBOT

Vicarious Surgical files $100M mixed securities shelf

16:37 EST Vicarious Surgical (RBOT) files $100M mixed securities shelf Published first on TheFly – the ultimate source...

3M ago

RBOT

Vicarious Surgical Announces Improved Cash Burn Outlook

An announcement from Vicarious Surgical ( ($RBOT) ) is now available. On December 1, 2025, Beverly Huss and...

4M ago

RBOT

Vicarious Surgical raises FY25 cash burn view to $45M from $50M

Vicarious Surgical (RBOT) announced an update to full-year 2025 financial guidance. Vicarious Surgical now expects full-year 2025 cash...

4M ago

RBOT

Vicarious Surgical’s Earnings Call Highlights Cost Management and Efficiency

Vicarious Surgical Inc. (($RBOT)) has held its Q3 earnings call. Read on for the main highlights of the...

4M ago

RBOT

RBOT FAQ

What was Vicarious Surgical’s price range in the past 12 months?

Vicarious Surgical lowest stock price was $0.27 and its highest was $13.75 in the past 12 months.

What is Vicarious Surgical’s market cap?

Vicarious Surgical’s market cap is $6.84M.

When is Vicarious Surgical’s upcoming earnings report date?

Vicarious Surgical’s upcoming earnings report date is May 11, 2026 which is in 48 days.

How were Vicarious Surgical’s earnings last quarter?

Vicarious Surgical released its earnings results on Mar 09, 2026. The company reported -$1.65 earnings per share for the quarter, missing the consensus estimate of -$1.37 by -$0.28.

Is Vicarious Surgical overvalued?

According to Wall Street analysts Vicarious Surgical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vicarious Surgical pay dividends?

Vicarious Surgical does not currently pay dividends.

What is Vicarious Surgical’s EPS estimate?

Vicarious Surgical’s EPS estimate is -1.2.

How many shares outstanding does Vicarious Surgical have?

Vicarious Surgical has 6,468,185 shares outstanding.

What happened to Vicarious Surgical’s price movement after its last earnings report?

Vicarious Surgical reported an EPS of -$1.65 in its last earnings report, missing expectations of -$1.37. Following the earnings report the stock price went up 24.259%.

Which hedge fund is a major shareholder of Vicarious Surgical?

Currently, no hedge funds are holding shares in RBOT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vicarious Surgical

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Vicarious Surgical (RBOT) Earnings & Revenues

Historic Earnings Reports

RBOT Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call reflects a company focused on reducing costs and improving operational efficiency, evident from significant reductions in operating expenses and successful fundraising efforts. However, challenges remain with high cash burn and potential disruptions due to outsourcing efforts. Additionally, the company has had to reduce its workforce to control costs.View all RBOT earnings summaries